• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.53% Nasdaq Up0.11%

    BioScrip, Inc. (BIOS)

    3.19 Down 0.08(2.45%) 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    BioScrip, Inc.
    10050 Crosstown Circle
    Suite 300
    Eden Prairie, MN 55344
    United States - Map
    Phone: 800-444-5951
    Website: http://www.bioscrip.com

    Index Membership:N/A
    Industry:Home Health Care
    Full Time Employees:1,955

    Business Summary 

    BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States. It operates in two segments, Infusion Services and PBM Services. The Infusion Services segment offers home infusion therapy and respiratory therapy services; and durable medical equipment, products, and services. Its services comprise home infusion services, including intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care; dispensing and administering of infusion-based drugs, which require nursing support and clinical management services; equipment to administer the dosage; and patient training. The PBM Services segment offers discount card programs that provide an alternative for individuals who may be uninsured, underinsured, or might have restrictive coverage, which disallows reimbursement for certain medications. The company was founded in 1993 and is based in Eden Prairie, Minnesota.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on BioScrip, Inc.

    Corporate Governance 
    BioScrip, Inc.’s ISS Governance QuickScore as of Jun 1, 2015 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 7; Compensation: 8.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Richard M. Smith , 55
    Chief Exec. Officer, Pres and Director
    Mr. Brian Stiver , 52
    Sr. VP of Sales & Marketing
    Mr. David Evans , 51
    Sr. VP of Strategic Operations & Reimbursement.
    Ms. Karen W. Cain , 60
    Chief Strategy and Transformation Officer and Sr. VP
    Mr. Jeffrey M. Kreger , 48
    Chief Financial Officer, Sr. VP and Treasurer
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders